Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 4521 - 4528 of 11613 results
Massachusetts Fall Legislative Preview
September 5, 2019| Blog| Viewpoint
Changes to Preference Practices Under New Bankruptcy Law
September 4, 2019| Blog| Viewpoint
Proposed H-1B Cap Registration Fee Rule Published by DHS
September 4, 2019| Alert| Viewpoint
Processing Delays Expected to Continue For All Trusted Traveler Program Applications
September 4, 2019| Blog| Viewpoint
New Convention Aims to Make Mediated Settlements an Attractive Means of Resolution of International Disputes . . . But Will It?
September 3, 2019| Blog| Viewpoint
ITC Domestic Industry Products Do Not Need to Be Commercially Available
September 3, 2019| Blog| Viewpoint
Part 2 Proposed Rule Brings Clarity and Reduces Regulatory Burdens for Substance Use Disorder Providers, but Challenges Remain
September 3, 2019| Blog| Viewpoint
Patent Prosecution and FDA Compliance Expenses May Help Satisfy the ITC’s Domestic Industry Requirement
September 3, 2019| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.